Hospital News and Research

RSS

Epileptic activity in brain can affect language development in children: Sahlgrenska Academy

Epileptic activity in the brain can affect language development in children, and EEG registrations should therefore be carried out more frequently on children with severe language impairment to identify more readily those who may need medical treatment, reveals a thesis from the Sahlgrenska Academy at the University of Gothenburg.

20 Apr 2010

FDA approves Lannett's ANDA for Ondansetron Injection USP, 2 mg/mL, Multi-Dose Vials

Lannett Company, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Ondansetron Injection USP, 2 mg/mL, Multi-Dose Vials. Ondansetron Injection USP, 2 mg/mL is the generic equivalent of GlaxoSmithKline's Zofran® Injection, 2 mg/mL. For the 12 months ending December 2009 U.S. sales of Ondansetron Injection USP, 2 mg/mL were approximately $58 million at Average Wholesale Price (AWP). A launch date for the product has not yet been set.

20 Apr 2010

Spacelabs Healthcare launches Ultraview DM3 vital signs monitor

Combining the simplistic performance of a spot-check monitor with the sophistication of continuous monitoring, Spacelabs Healthcare's Ultraview DM3 provides caregivers with a dual-mode solution for accurately and efficiently measuring vital signs (SpO2, pulse rate, non-invasive blood pressure, respiration and temperature) on adult and pediatric patients.

20 Apr 2010

Magen Medical Solutions announces successful implantation of SpineShield anti-adhesion device

Magen Medical Solutions Ltd., a medical device company developing unique anti-adhesion devices for orthopedic applications, is pleased to announce that it has successfully implanted its first product, the SpineShield, in three patients at a clinical site in Europe.

19 Apr 2010

Jennerex presents positive interim data from Phase 2 clinical trial of JX-594 for HCC at 45th EASL

Jennerex, Inc., a clinical-stage cancer biotherapeutics company, today announced the presentation of positive interim data from its randomized Phase 2 clinical trial using JX-594 for the treatment of advanced hepatocellular carcinoma (HCC), or liver cancer, at the 45th Annual Meeting of the European Association for the Study of the Liver (EASL) in Vienna, Austria.

19 Apr 2010

ConvaTec's Vitala Continence Control Device receives 2010 Medical Design Excellence Award

ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today that the Vitala™ Continence Control Device (CCD) has received a 2010 Medical Design Excellence Award.

19 Apr 2010

BioMarin Pharmaceutical introduces Firdapse for LEMS in the E.U.

BioMarin Pharmaceutical Inc. announced today that Firdapse™ (3,4-diaminopyridine) is now commercially available in the European Union (E.U.) for the treatment of the rare autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS). Launching immediately in Germany and the UK, the company expects to subsequently launch Firdapse in all major European markets by the end of 2010.

19 Apr 2010

Biomarkers to help predict development of aggressive colorectal cancer discovered

Researchers at the University of Alabama at Birmingham (UAB) Department of Pathology have discovered a set of four biomarkers that will help predict which patients are more likely to develop aggressive colorectal cancer and which are not. The findings also shed light on the genetics that result in worse colorectal cancer-treatment outcomes for African-Americans, compared with Caucasians, the researchers said.

19 Apr 2010

Michigan medical equipment suppliers unhappy about Medicare competitive bidding

Crain's Detroit Business: A regulatory change by the Centers for Medicare and Medicaid Services "could put a crimp on hospital-based medical home product subsidiaries and hundreds of other Michigan-based vendors," an industry that has been growing.

19 Apr 2010

Valedictory Symposium to celebrate Professor David Taylor's contribution to Obstetrics and Gynaecology

Medical experts from across the UK are gathering at the University of Leicester on Friday 23rd April in a Valedictory Symposium to celebrate the work of Professor David Taylor.

19 Apr 2010

NDA for Cadence Pharmaceuticals' OFIRMEV injection to be re-submitted to FDA

Cadence Pharmaceuticals, Inc. announced today that, based on feedback received during a meeting with the U.S. Food and Drug Administration on April 16, 2010, it plans to re-submit a New Drug Application for its investigational product candidate, OFIRMEV (acetaminophen) injection, within the next 30 days.

19 Apr 2010

Sentry Air Systems announces equipment compliance with OSHA's hexavalent chromium regulation

The Occupational Health and Safety Administration (OSHA) is enforcing strict regulations regarding worker exposure to hexavalent chromium in several industries. Hexavalent chromium, a volatized and oxidized form of chromium, has been identified as a carcinogen. OSHA has subsequently established stringent regulations for workers who are potentially exposed to it in the general, construction, shipyard, and marine terminal industries.

19 Apr 2010

Smith & Nephew highlights advanced wound care product portfolio at 2010 SAWC/WHS meeting

The Advanced Wound Management division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew plc announced today that a total of 16 posters on studies conducted with its advanced wound care products were presented at this year's Symposium on Advanced Wound Care (SAWC) and Wound Healing Society (WHS) meeting.

19 Apr 2010

Ontario hospital representatives meet to set prices for hospital clinical services

200 representatives from 65 Ontario hospital corporations represented by CUPE meet in Thunder Bay from Monday through Wednesday. On their agenda is the plan announced in the Throne Speech to set prices for hospital clinical services and tender those services to the lowest bidder.

19 Apr 2010

The Leapfrog Group selects Quantros to service and administer online Leapfrog Hospital Survey

The Leapfrog Group has selected Quantros, a leading healthcare software and services provider of data management, decision support analytics, and clinical business intelligence solutions, to service and administer the online Leapfrog Hospital Survey.

19 Apr 2010

First US implant of Interventional Spine's RENEW Interspinous Allograft Technology for LSS

Interventional Spine, Inc. today announced the first commercial implant in the United States of its RENEW™ Interspinous Allograft Technology for the Treatment of Lumbar Spinal Stenosis (LSS).

19 Apr 2010

End-of-life care documentation helps in emergency treatment decisions

When Heather Rubesch was a teenager, her aunt died in need of a kidney transplant. In later family discussions, Heather's mother, Linda, expressed some of her views about end-of-life care—for instance, her belief in organ donation.

19 Apr 2010

Exposure to dust after WTC collapse impairs ability to detect odors and sense irritants

Individuals involved in rescue, recovery, demolition, and clean-up after the World Trade Center (WTC) disaster on September 11, 2001, were exposed to a complex mixture of airborne smoke, dust, combustion gases, acid mists, and metal fumes. The impact of this exposure on responders' upper and lower respiratory function has been well documented, but little is known about its impact on their sensitivity to odor and irritants.

19 Apr 2010

Radiolabeled hedgehog can differentiate stem-like cancer cells, identify aggressive tumors

At the American Association for Cancer Research 101st Annual Meeting 2010, scientists and clinicians will present more than 6,300 abstracts dealing with innovative aspects of biology, technology and emerging therapies.

19 Apr 2010

New p53 knockout rat model improves timelines for carcinogenicity screening

Sigma Life Science, the innovative biological products and services brand of Sigma-Aldrich, today introduced the world's first p53 'knockout' rat model, an important development that is expected to, due to the rat's closer physiological and metabolic similarity to humans, significantly improve timelines for carcinogenicity screening and reduce time to market for therapeutics.

19 Apr 2010

Hospital News and Research

Epileptic activity in brain can affect language development in children: Sahlgrenska Academy

FDA approves Lannett's ANDA for Ondansetron Injection USP, 2 mg/mL, Multi-Dose Vials

Spacelabs Healthcare launches Ultraview DM3 vital signs monitor

Magen Medical Solutions announces successful implantation of SpineShield anti-adhesion device

Jennerex presents positive interim data from Phase 2 clinical trial of JX-594 for HCC at 45th EASL

ConvaTec's Vitala Continence Control Device receives 2010 Medical Design Excellence Award

BioMarin Pharmaceutical introduces Firdapse for LEMS in the E.U.

Biomarkers to help predict development of aggressive colorectal cancer discovered

Michigan medical equipment suppliers unhappy about Medicare competitive bidding

Valedictory Symposium to celebrate Professor David Taylor's contribution to Obstetrics and Gynaecology

NDA for Cadence Pharmaceuticals' OFIRMEV injection to be re-submitted to FDA

Sentry Air Systems announces equipment compliance with OSHA's hexavalent chromium regulation

Smith & Nephew highlights advanced wound care product portfolio at 2010 SAWC/WHS meeting

Ontario hospital representatives meet to set prices for hospital clinical services

The Leapfrog Group selects Quantros to service and administer online Leapfrog Hospital Survey

First US implant of Interventional Spine's RENEW Interspinous Allograft Technology for LSS

End-of-life care documentation helps in emergency treatment decisions

Exposure to dust after WTC collapse impairs ability to detect odors and sense irritants

Radiolabeled hedgehog can differentiate stem-like cancer cells, identify aggressive tumors

New p53 knockout rat model improves timelines for carcinogenicity screening

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News